Tasly Pharmaceutical Group (SHA:600535) has an average rating of buy and mean price target of 17.29 yuan, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)